Infant formulas are the sole or predominant source of nutrition for many infants and are fed during a sensitive period of development and may therefore have short- and long-term consequences for infant health. Preclinical safety assessment therefore needs to include both short-term and long-term studies in animals. It is recommended that procedures are instituted by which experts may serve as independent scientists for companies developing novel products, without having their integrity compromised, and later serve the legislative institutions. A two-level assessment approach to determine the potential toxicity of a novel ingredient, its metabolites, and their effects in the matrix on developing organ systems has been suggested by IOM. This appears reasonable, as novel ingredients can be of different levels of concern. The use of modern methods in genomics and proteomics should be considered in these evaluation processes as well as novel methods to evaluate outcomes, including metabolomics and molecular techniques to assess the microbiome.

Keywords:
Safety, Infant formula, Novel ingredients, Toxicity
1.
Aggett PJ, Agostini C, Goulet O, Hernell O, Koletzko B, Lafeber HL, Michaelsen KF, Rigo J, Weaver LT; European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition: The nutritional and safety assessment of breast milk substitutes and other dietary products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2001;32:256–258.
2.
Life Sciences Research Office (LSRO): LSRO report: assessment of nutrient requirements for infant formulas. J Nutr 1998;128:2059S–2293S.
3.
Koletzko B, Baker S, Cleghorn G, Neto UF, Gopalan S, Hernell O, Hock QS, Jirapinyo P, Lönnerdal B, Pencharz P, Pzyrembel H, Ramirez-Mayans J, Shamir R, Turck D, Yamashiro Y, Zong-Yi D: Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr 2005;41:584–599.
4.
Food and Drug Administration: Current good manufacturing practice, quality control procedures, quality factors, notification requirements, and records and reports, for the production of infant formula. Proposed rule. Fed Regist 1996;61:36153–36219.
5.
Office of Food Additive Safety: Toxicological Principles for the Safety Assessment of Direct Food Additives and Color Additives Used in Food. Redbook II-Draft. Washington DC, OFAS, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 2001.
6.
Grossklaus R: Codex recommendations on the scientific basis of health claims. Eur J Nutr 2009;48(suppl 1):S15–S22.
7.
Koletzko B: Health claims: let science prevail. Ann Nutr Metab 2011;58:79–81.
8.
Institute of Medicine: Infant formula: evaluating the safety of new ingredients. Washington, DC, National Academies Press, 2004.
9.
Houle VM, Schroeder EA, Odle J, Donovan SM: Small intestinal disaccharidase activity and ileal villus height are increased in piglets consuming formula containing recombinant human insulin-like growth factor-I. Pediatr Res 1997;42:78–86.
10.
Herfel TM, Jacobi SK, Lin X, Walker DC, Jouni ZE, Odle J: Safety evaluation of polydextrose in infant formula using a suckling piglet model. Food Chem Toxicol 2009;47:1530–1537.
11.
Puiman PJ, Jensen M, Stoll B, Renes IB, de Bruijn AC, Dorst K, Schierbeek H, Schmidt M, Boehm G, Burrin DG, Sangild PT, van Goudoever JB: Intestinal threonine utilization for protein and mucin synthesis is decreased in formula-fed preterm pigs. J Nutr 2011;141:1306–1311.
12.
Lönnerdal B, Jayawickrama L, Lien EL: Effect of reducing the phytate content and of partially hydrolyzing the protein in soy formula on zinc and copper absorption and status in infant rhesus monkeys and rat pups. Am J Clin Nutr 1999;69:490–496.
13.
Lönnerdal B, Kelleher SL, Lien EL: Extent of thermal processing of infant formula affects copper status in infant rhesus monkeys. Am J Clin Nutr 2001;73:914–919.
14.
Kelleher SL, Casas I, Carbajal N, Lönnerdal B: Supplementation of infant formula with the probiotic lactobacillus reuteri and zinc: impact on enteric infection and nutrition in infant rhesus monkeys. J Pediatr Gastroenterol Nutr 2002;35:162–168.
15.
Brück WM, Kelleher SL, Gibson GR, Nielsen KE, Chatterton DE, Lönnerdal B: rRNA probes used to quantify the effects of glycomacropeptide and alpha-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr 2003;37:273–280.
16.
Lien EL: Toxicology and safety of DHA. Prostaglandins Leukot Essent Fatty Acids 2009;81:125–132.
17.
Boyle FG, Wrenn JM, Marsh BB, Anderson WI, Angelosanto FA, McCartney AL, Lien EL: Safety evaluation of oligofructose: 13 week rat study and in vitro mutagenicity. Food Chem Toxicol 2008;46:3132–3139.
18.
Daniel H: Genomics and proteomics: importance for the future of nutrition research. Br J Nutr 2002;87:S305–S311.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.